Foxy-5 sin sodium salt(Coban) intragastric pretreatment with S-(+)-Rolipram dose-dependently

intragastric pretreatment with S-(+)-Rolipram dose-dependently reduces both the OA-induced decreases in specific conductance as well as the corresponding pulmonary eosinophil influx as assessed by both bronchoalveolar lavage and histological evaluation

C[C@H](CCC(=O)NCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O

J Clin Pharmacol

InChiKey: VEYWWAGBHABATA-UHFFFAOYSA-N

Foxy-5 sin sodium salt(Coban) intragastric pretreatment with S-(+)-Rolipram dose-dependentlyFoxy 5, a Wnt 5a mimicking hexapeptide, is a WNT signalling pathway modulator potentially for the treatment of metastatic breast cancer, prostate cancer and colorectal cancer. Product information CAS Number: 881188 51 8 Molecular Weight: 694. 77 Formula: C26H42N6O12S2 Chemical Name: (2S,5S,8R,14S) 5 (2 carboxyethyl) 14 ((S) 2 formamido 4 (methylthio)butanamido) 2 isobutyl 8 (mercaptomethyl) 4,7,10,13 tetraoxo 3,6,9,12 tetraazahexadecanedioic acid